Sten Thorstenson
Linköping University
17 Papers
194 Citations
Sten Thorstenson is an academic researcher from Linköping University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 12, co-authored 17 publications.
Chat about Author
Papers
Implementation of large-scale routine diagnostics using whole slide imaging in Sweden: Digital pathology experiences 2006-2013
TL;DR: The fact that two full-scale digital systems have been implemented and that a large portion of the primary reporting is voluntarily performed digitally shows that large-scale digitization is possible today.
168
Tumor-Specific Expression of Vascular Endothelial Growth Factor Receptor 2 but Not Vascular Endothelial Growth Factor or Human Epidermal Growth Factor Receptor 2 Is Associated With Impaired Response to Adjuvant Tamoxifen in Premenopausal Breast Cancer
Lisa Rydén,Karin Jirström,Pär-Ola Bendahl,Mårten Fernö,Bo Nordenskjöld,Olle Stål,Sten Thorstenson,Per-Ebbe Jönsson,Göran Landberg +8 more
TL;DR: Tumor-specific expression of VEGFR2 was associated with an impaired tamoxifen effect in hormone receptor-positive premenopausal breast cancer, and tamoxIFen in combination with VEG FR2 inhibitors might be a novel treatment approach for VEGfr2-expressing breast cancer and such a treatment might restore the tamox ifen response.
83
Incidence and prognosis in early onset breast cancer
TL;DR: Lymph node status was the strongest sole prognostic indicator but the use of NPI gave more accurate prognostic information than node status alone, and the survival rate has not improved during the last 35 years.
74
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.
Karin Jirström,Lisa Rydén,L Anagnostaki,Bo Nordenskjöld,Olle Stål,Sten Thorstenson,Gunilla Chebil,P-E Jonsson,Mårten Fernö,Göran Landberg +9 more
TL;DR: Clinically established pathology parameters seem to mirror the endocrine treatment response and could potentially be valuable in future treatment decisions for patients with breast cancer.
Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study
Gábor Cserni,Simonetta Bianchi,Vania Vezzosi,Riccardo Arisio,Rita Bori,Johannes L. Peterse,Anna Sapino,Isabella Castellano,Maria Drijkoningen,Janina Kulka,Vincenzo Eusebi,Maria Pia Foschini,Jean Pierre Bellocq,Cristi Marin,Sten Thorstenson,Isabel Amendoeira,Angelika Reiner-Concin,Thomas Decker,Manuela Lacerda,Paulo Figueiredo,Gábor Fejes +20 more
TL;DR: Sentinel lymph node (SLN) biopsy has become the preferred method for the nodal staging of early breast cancer, but controversy exists regarding its universal use and consequences in small tumors.
46